🔎 Trials Near Me

首页 › 急性髓系白血病 › 南卡罗来纳州 › Greenville

Greenville SC 急性髓系白血病临床试验

10项针对 急性髓系白血病的研究正在 Greenville及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。

官方研究文本（英文）

正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

招募中2 期
  • Prisma Health Cancer Institute - Butternut, Greenville
  • Prisma Health Cancer Institute - Faris, Greenville
  • Prisma Health Cancer Institute - Eastside, Greenville
18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

招募中观察性研究欢迎健康志愿者
  • Prisma Health Cancer Institute - Faris, Greenville
  • Prisma Health Greenville Memorial Hospital, Greenville
40 至 75 岁 · 所有性别 · 更新于 2026年10月2日 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

招募中2 期
  • Prisma Health Cancer Institute - Butternut, Greenville
  • Prisma Health Cancer Institute - Faris, Greenville
  • Prisma Health Cancer Institute - Eastside, Greenville
18 至 59 岁 · 所有性别 · 更新于 2026年9月28日 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

招募中2 期
  • Prisma Health Cancer Institute - Butternut, Greenville
  • Prisma Health Cancer Institute - Faris, Greenville
  • Prisma Health Cancer Institute - Eastside, Greenville
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

招募中2 期
  • Prisma Health Cancer Institute - Butternut, Greenville
  • Prisma Health Cancer Institute - Faris, Greenville
  • Prisma Health Cancer Institute - Eastside, Greenville
18 至 59 岁 · 所有性别 · 更新于 2026年9月22日 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

招募中2 期
  • Prisma Health Cancer Institute - Butternut, Greenville
  • Prisma Health Cancer Institute - Faris, Greenville
  • Prisma Health Cancer Institute - Eastside, Greenville
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

招募中3 期
  • BI-LO Charities Children's Cancer Center, Greenville
6 Months – 21 Years · 所有性别 · 更新于 2026年9月17日 · NCT04293562

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

招募中1/2 期
  • Bon Secours St. Francis Cancer Center, Greenville
12 岁及以上 · 所有性别 · 更新于 2026年9月3日 · NCT04588922

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

招募中1/2 期
  • BI-LO Charities Children's Cancer Center, Greenville
22 岁及以下 · 所有性别 · 更新于 2026年8月25日 · NCT04726241

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

招募中1 期
  • Prisma Health, Greenville
18 岁及以上 · 所有性别 · 更新于 2026年8月20日 · NCT06001788

其他城市的 急性髓系白血病试验

Greenville的其他研究

数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。